Novel yeast cell-based assay to screen for inhibitors of human cytomegalovirus protease in a high-throughput format

被引:16
作者
Cottier, V [1 ]
Barberis, A [1 ]
Lüthi, U [1 ]
机构
[1] ESBATech AG, CH-8952 Zurich, Switzerland
关键词
D O I
10.1128/AAC.50.2.565-571.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The protease encoded by the human cytomegalovirus (HCMV) is an attractive target for antiviral drug development because of its essential function in viral replication. We describe here a cellular assay in the yeast Saccharomyces cerevisiae for the identification of small molecule inhibitors of HCMV protease by conditional growth in selective medium. In this system, the protease cleavage sequence is inserted into the N-(5'-phosphoribosyl)anthranilate isomerase (Trp1p), a yeast protein essential for cell proliferation in the absence of tryptophan. Coexpression of HCMV protease with the engineered Trp1p substrate in yeast cells results in site-specific cleavage and functional inactivation of the Trp1p enzyme, thereby leading to an arrest of cell proliferation. This growth arrest can be suppressed by the addition of validated HCMV protease inhibitors. The growth selection system presented here provides the basis for a high-throughput screen to identify HCMV protease inhibitors that are active in eukaryotic cells.
引用
收藏
页码:565 / 571
页数:7
相关论文
共 42 条
[1]   Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture [J].
Abood, NA ;
Schretzman, LA ;
Flynn, DL ;
Houseman, KA ;
Wittwer, AJ ;
Dilworth, VM ;
Hippenmeyer, PJ ;
Holwerda, BC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (16) :2105-2108
[2]  
[Anonymous], 1996, Fields virology
[3]  
Barberis A, 2002, EUROPEAN BIOPHAR WIN, P93
[4]  
Barberis Alcide, 2005, Drug Discov Today Technol, V2, P187, DOI 10.1016/j.ddtec.2005.05.022
[5]   Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease [J].
Batra, R ;
Khayat, R ;
Tong, L .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (09) :810-817
[6]   Design of translactam HCMV protease inhibitors as potent antivirals [J].
Borthwick, AD .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (04) :427-452
[7]   HUMAN CYTOMEGALOVIRUS MATURATIONAL PROTEINASE - EXPRESSION IN ESCHERICHIA-COLI, PURIFICATION, AND ENZYMATIC CHARACTERIZATION BY USING PEPTIDE SUBSTRATE MIMICS OF NATURAL CLEAVAGE SITES [J].
BURCK, PJ ;
BERG, DH ;
LUK, TP ;
SASSMANNSHAUSEN, LM ;
WAKULCHIK, M ;
SMITH, DP ;
HSIUNG, HM ;
BECKER, GW ;
GIBSON, W ;
VILLARREAL, EC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2937-2946
[8]  
Burke D., 2000, Methods in Yeast Genetics Plainview, NY, V2000
[9]   Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad [J].
Chen, P ;
Tsuge, H ;
Almassy, RJ ;
Gribskov, CL ;
Katoh, S ;
Vanderpool, DL ;
Margosiak, SA ;
Pinko, C ;
Matthews, DA ;
Kan, CC .
CELL, 1996, 86 (05) :835-843
[10]   New inhibitors of human cytomegalovirus (HCMV) on the horizon [J].
De Clercq, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) :1079-1083